These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

531 related articles for article (PubMed ID: 20145275)

  • 21. Acute leukemias with complex karyotype show a similarly poor outcome independent of mixed, myeloid or lymphoblastic immunophenotype: A study from the Bone Marrow Pathology Group.
    Kirtek T; Chen W; Laczko D; Bagg A; Koduru P; Foucar K; Venable E; Nichols M; Rogers HJ; Tam W; Orazi A; Hsi ED; Hasserjian RP; Wang SA; Arber DA; Weinberg OK
    Leuk Res; 2023 Jul; 130():107309. PubMed ID: 37210875
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flow cytometric analysis of Mixed phenotype acute leukemia: experience from a tertiary oncology center.
    Sukumaran R; Nair RA; Jacob PM; Nair Anila KA; Prem S; Binitha R; Kusumakumary P
    Indian J Pathol Microbiol; 2015; 58(2):181-6. PubMed ID: 25885130
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genomic Landscape of Mixed-Phenotype Acute Leukemia.
    Hennawi M; Pakasticali N; Tashkandi H; Hussaini M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232559
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinico-hematological and immunophenotypic profile of acute leukemia of ambiguous lineage: A four year experience from a single tertiary care centre of West India.
    Rai V; Brahmbhatt B; Saha A; Thayakaran IP
    Indian J Pathol Microbiol; 2024; 67(1):121-127. PubMed ID: 38358200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular characterization of V(D)J rearrangements in immature acute leukemias.
    Vianna DT; Reis Monte-Mór BDC; Noronha EP; Gutiyama LM; da Costa ES; Pombo-de-Oliveira MS; Zalcberg I
    Leuk Res; 2024 Aug; 143():107521. PubMed ID: 38879405
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mixed-phenotype acute leukemia: suboptimal treatment when the 2008/2016 WHO classification is used.
    Pomerantz A; Rodriguez-Rodriguez S; Demichelis-Gomez R; Barrera-Lumbreras G; Barrales-Benitez O; Lopez-Karpovitch X; Aguayo-Gonzalez A
    Blood Res; 2016 Dec; 51(4):233-241. PubMed ID: 28090485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical and laboratorial analysis for 15 adult cases of mixed phenotypic acute leukemia with Ph chromosome and/or positive BCR-ABL].
    Yan LZ; Chen SN; Ping NN; Wang QR; Liu H; Ding ZX; Zhu MQ; Liang JY; Liu DD; Cen JN; Pan JL; Qiu HY; Sun AN; Wu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Oct; 21(5):1116-20. PubMed ID: 24156417
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Redefining the biological basis of lineage-ambiguous leukemia through genomics: BCL11B deregulation in acute leukemias of ambiguous lineage.
    Montefiori LE; Mullighan CG
    Best Pract Res Clin Haematol; 2021 Dec; 34(4):101329. PubMed ID: 34865701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T-lymphoid/myeloid mixed phenotype acute leukemia and early T-cell precursor lymphoblastic leukemia similarities with
    Noronha EP; Marques LVC; Andrade FG; Sardou-Cezar I; Dos Santos-Bueno FV; Zampier CDP; Terra-Granado E; Pombo-de-Oliveira MS
    Cancer Manag Res; 2019; 11():3933-3943. PubMed ID: 31118806
    [No Abstract]   [Full Text] [Related]  

  • 30. Biphenotypic acute leukemia with coexpression of CD79a and markers of myeloid lineage.
    Frater JL; Yaseen NR; Peterson LC; Tallman MS; Goolsby CL
    Arch Pathol Lab Med; 2003 Mar; 127(3):356-9. PubMed ID: 12653584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Non-leukemic pediatric mixed phenotype acute leukemia/lymphoma: Genomic characterization and clinical outcome in a prospective trial for pediatric lymphoblastic lymphoma.
    Martin-Guerrero I; Salaverria I; Burkhardt B; Chassagne-Clement C; Szczepanowski M; Bens S; Klapper W; Zimmermann M; Kabickova E; Bertrand Y; Reiter A; Siebert R; Oschlies I
    Genes Chromosomes Cancer; 2019 Jun; 58(6):365-372. PubMed ID: 30578714
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
    van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
    Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Definition of acute biphenotypic leukemia.
    Matutes E; Morilla R; Farahat N; Carbonell F; Swansbury J; Dyer M; Catovsky D
    Haematologica; 1997; 82(1):64-6. PubMed ID: 9107085
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicoepidemiologic Profile and Outcome Predicted by Minimal Residual Disease in Children With Mixed-phenotype Acute Leukemia Treated on a Modified MCP-841 Protocol at a Tertiary Cancer Institute in India.
    Myint HH; Tandon S; Narula G; Prasad M; Subramanian P; Patkar N; Tembhare P; Gujral S; Banavali S
    J Pediatr Hematol Oncol; 2020 Oct; 42(7):415-419. PubMed ID: 32976349
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunophenotypic patterns of childhood acute leukemias in Indonesia.
    Supriyadi E; Widjajanto PH; Veerman AJ; Purwanto I; Nency YM; Gunawan S; Nafianti S; Purnomosari D; Intansari US; Westra G; Cloos J
    Asian Pac J Cancer Prev; 2011; 12(12):3381-7. PubMed ID: 22471485
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An update on classification, genetics, and clinical approach to mixed phenotype acute leukemia (MPAL).
    Khan M; Siddiqi R; Naqvi K
    Ann Hematol; 2018 Jun; 97(6):945-953. PubMed ID: 29546454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mixed-phenotypic acute leukemia series from tertiary care center.
    Pawar RN; Banerjee S; Bramha S; Krishnan S; Bhattacharya A; Saha V; Chakrapani A; Bhave S; Chandy M; Nair R; Parihar M; Arora N; Mishra DK
    Indian J Pathol Microbiol; 2017; 60(1):43-49. PubMed ID: 28195090
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparison of EGIL1998 and WHO2008 criteria for the diagnosis of mixed phenotype acute leukemia].
    Ye L; Lin D; Mi YC; Zhang J; Wang Y; Wang HJ; Wei H; Liu BC; Zhou CL; Li W; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2012 Apr; 33(4):286-90. PubMed ID: 22781719
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunophenotypic but Not Genetic Changes Reclassify the Majority of Relapsed/Refractory Pediatric Cases of Early T-Cell Precursor Acute Lymphoblastic Leukemia.
    Demina I; Dagestani A; Borkovskaia A; Semchenkova A; Soldatkina O; Kashpor S; Olshanskaya Y; Roumiantseva J; Karachunskiy A; Novichkova G; Maschan M; Zerkalenkova E; Popov A
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891797
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.